Literature DB >> 8172612

Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

G Pejler1, K Söderström, A Karlström.   

Abstract

Rat peritoneal mast cells were shown to inactivate thrombin rapidly. The thrombin-inactivating activity was purified to homogeneity by a combination of anion-exchange chromatography and h.p.l.c. on a Superdex 75 column. The purified thrombin inactivator had an apparent molecular mass of 29 kDa and an N-terminal amino acid sequence identical to rat mast-cell protease 1 (RMCP-1). After labelling of the mast cells in vivo with 35SO4(2-), RMCP-1 was recovered in a macromolecular complex with [35S]heparin proteoglycans. Dissociation of RMCP-1 from the heparin proteoglycans by Superdex 75 chromatography in the presence of 2 M NaCl resulted in a marked loss of the thrombin-inactivating activity displayed by the enzyme. When RMCP-1 was reconstituted with either endogenous [35S]heparin proteoglycans or standard pig mucosal heparin, the enzyme regained its thrombin-inactivating properties. Affinity chromatography of endogenous [35S]heparin on matrix-linked RMCP-1 demonstrated that all of the heparin molecules contained high-affinity binding sites for the mast-cell protease. In contrast, the endogenous mast-cell heparin showed low affinity for antithrombin, a protease inhibitor involved in the regulation of coagulation enzymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172612      PMCID: PMC1138300          DOI: 10.1042/bj2990507

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Identification of a chymotrypsin-like proteinase in human mast cells.

Authors:  N M Schechter; J K Choi; D A Slavin; D T Deresienski; S Sayama; G Dong; R M Lavker; D Proud; G S Lazarus
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

2.  Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells.

Authors:  G Pejler; G David
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and a multi-gene family.

Authors:  P N Benfey; F H Yin; P Leder
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

4.  Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.

Authors:  R Hattori; K K Hamilton; R D Fugate; R P McEver; P J Sims
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

5.  Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.

Authors:  S Sayama; R V Iozzo; G S Lazarus; N M Schechter
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

6.  Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker.

Authors:  W E Serafin; E T Dayton; P M Gravallese; K F Austen; R L Stevens
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

7.  The role of mast cells in thioglycollate-induced inflammation.

Authors:  R Qureshi; B A Jakschik
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

8.  Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer.

Authors:  L B Schwartz; T R Bradford
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

9.  A prothrombinase complex of mouse peritoneal macrophages.

Authors:  U Lindahl; G Pejler; J Bøgwald; R Seljelid
Journal:  Arch Biochem Biophys       Date:  1989-08-15       Impact factor: 4.013

10.  Amino acid sequence of rat mast cell protease I (chymase).

Authors:  H Le Trong; D C Parmelee; K A Walsh; H Neurath; R G Woodbury
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

View more
  8 in total

1.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

2.  Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.

Authors:  G Pejler
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

3.  Immunological modulation of human cardiac mast cells.

Authors:  G Marone; G de Crescenzo; G Florio; F Granata; V Dente; A Genovese
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

Review 4.  Mast Cell and Basophil Granule Proteases - In Vivo Targets and Function.

Authors:  Lars Hellman; Srinivas Akula; Zhirong Fu; Sara Wernersson
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

5.  Cloning of the cDNAs for mast-cell chymases from the jejunum of Mongolian gerbils, Meriones unguiculatus, and their sequence similarities with chymases expressed in the connective-tissue mast cells of mice and rats.

Authors:  H Itoh; Y Murakumo; M Tomita; H Ide; T Kobayashi; H Maruyama; Y Horii; Y Nawa
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

6.  Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases.

Authors:  H Ide; H Itoh; M Tomita; Y Murakumo; T Kobayashi; H Maruyama; Y Osada; Y Nawa
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

7.  Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations.

Authors:  C Lützelschwab; G Pejler; M Aveskogh; L Hellman
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

Review 8.  Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals.

Authors:  Lars Torkel Hellman; Srinivas Akula; Michael Thorpe; Zhirong Fu
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.